Childhood obesity is rising globally. It can have lifelong implications
On the surface, problems with weight may seem simple – the body stores excess energy from food as fat. But the reality is that obesity is a complex chronic disease which can be caused by many interlinked factors. Key Points
ThePrintIndian govt needs to trim citizens' waist size for the sake of economy
India's Economic Survey 2023-24 warned that increasing obesity rates could hinder the country's economic potential. Experts urged the government to promote healthier lifestyles through better diet, physical activity, and monitoring of health parameters. Emphasizing waist circumference and BMI, they suggested that addressing obesity is crucial to reaping India's demographic dividend. Key Points
Economic TimesBMI alone not sufficient, waist-to-height ratio more effective in diagnosing obesity: Researchers
Accumulation of abdominal fat is a more reliable predictor of health deterioration, compared to BMI. obesity can no longer be just defined by body mass index... Key Points
The Tribune IndiaChildren with severe obesity at age 4 may have a life expectancy of just 39: Study
The study included more than 10 million participants from countries around the world, approximately 2.7 million of whom were aged between 2 and 29 years.. A... Key Points
The Tribune IndiaWorld obesity Day 2024: Healthy habits for kids to prevent childhood obesity
Is your child overweight or obese? Do not ignore the extra weight, as it can cause deadly complications later in life. Make these lifestyle changes. | Health Key Points
Hindustan Times
Global malnourishment: 1 in 8 people are obese
New data from The Lancet suggests fewer people are starving across the globe. But obesity is taking its place. | Health Key Points
Hindustan TimesOver a billion people struggling with obesity globally: Lancet study
According to a new Lancet global study, the prevalence of obesity among adults has more than doubled since 1990 and quadrupled among children and adolescents aged 5 to 19. India not only showed a burden of obesity, it also showed a burden of underweight among children. Key Points
India Today82.5 mn Indians were 'obese' in 2022, shows Lancet study. Doctors, nutritionists say 'tip of iceberg'
Study, conducted by NCD Risk Factor Collaboration & WHO, shows that nearly 880 million adults globally living with obesity in 2022 — 4.5 times higher than the number recorded in 1990. Key Points
ThePrintWeight-loss drugs: Who, and what, are they good for?
The new drugs are known as GLP-1 agonists, which mimic the activity of a hormone that slows digestion and helps people feel full for longer. In clinical trials, people lost 15% to 20% of their body weight, depending on the drug. Nearly 120 million American adults could be eligible for treatment, while Novo says its target market is more than 760 million people with obesity worldwide. Key Points
Economic TimesMaker of Wegovy, Ozempic showers money on U.S. obesity doctors
Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, a Reuters analysis found. It concentrated that money on an elite group of obesity specialists who advocate giving its powerful and expensive drugs to tens of millions of Americans. Key Points
Reuters
Scientists decode what drives obesity
Nutritional experts have for years debated on the primary culprit for increasing obesity. While diets that are high in fat and carbohydrates contribute to the condition, it turns out, fructose may be one true driver of obesity, according to a study. Key Points
The Tribune IndiaHow Queen Latifah is changing the conversation around obesity
Queen Latifah is reshaping the conversation about obesity. The actor shares how she was first body-shamed in third grade. She is now advocating for better care for those with obesity. Key Points
InsiderStudy finds how obesity increases mental disorders risk throughout life
Vienna [Austria], May 30 (ANI): obesity increases the likelihood of having mental illnesses considerably. This applies to all age groups, with women having a higher risk of most diseases than males, according to a recent study conducted by the Complexity Science Hub and the Medical University of Vienna. The findings of the study were published […] Key Points
ThePrintStudy reveals how people with obesity due to genetic tendency have lower risk of cardiovascular disease
Solna [Sweden], April 6 (ANI): Researchers found that those with obesity who have a genetic tendency for high BMI have a lower risk of cardiovascular disease than those whose obesity is mostly caused by environmental factors like lifestyle. The result from Karolinska Institutet report in eClinicalMedicine. There has been a global increase in the incidence […] Key Points
ThePrintExclusive: WHO to consider adding obesity drugs to 'essential' medicines list
Drugs that combat obesity are under consideration for the first time for the World Health Organization's "essential medicines list," used to guide government purchasing decisions in low- and middle-income countries, the U.N. agency told Reuters. Key Points
Reuters
WHO to consider adding obesity drugs to 'essential' medicines list
Drugs that combat obesity could for the first time be included on the World Health Organization’s (WHO) “essential medicines list,” used to guide government purchasing decisions in low- and middle-income countries, the U.N. agency told Reuters. A panel of advisers to the WHO will review new requests for drugs to be included next month, with an updated essential medicines list due in September. Key Points
The HinduMental health: Here's how obesity impacts social life, psychological illness
Obesity and mental health issues often coexist and are together referred to as the twin epidemic. It is seen that psychological issues may lead to obesity and some-times obesity may lead to issues like depression. Expert reveals how | Health Key Points
Hindustan TimesWeight loss tips: 10 lifestyle changes to reverse, prevent or manage obesity
An unhealthy lifestyle, irrespective of your weight, can put you at risk of many lifestyle diseases from diabetes to heart ailments to cancer. It is important to take care of your body weight and reverse obesity. Here are 10 lifestyle changes suggested by experts. | Health Key Points
Hindustan TimesEconomists warn of costs if Medicare covers new obesity drugs
The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday. Key Points
ReutersAltimmune open to partnerships, deals with drugmakers, says CEO
Weight-loss drug developer Altimmune (ALT.O) is open to deals and collaborations with large drugmakers as it actively looks for partners to launch and develop its experimental obesity drug, CEO Vipin Garg told Reuters on Tuesday. Key Points
ReutersCryotherapy, a form of extreme cold exposure, lowered blood sugar and cholesterol for obesity patients in a new study
Cryotherapy helped lower blood sugar and cholesterol in obese patients in a small study. The practice exposes the body to extremely cold temperatures. Key Points
Insider12.5 million children, teens in India obese in 2022: Study
Among adults, the global obesity rate more than doubled in women and nearly tripled in men. About 12.5 million children aged between five and 19 in India... Key Points
The Tribune IndiaAstraZeneca raises stakes in obesity drug race with Eccogene deal
AstraZeneca (AZN.L) moved on Thursday to boost its drugs pipeline in the booming anti-obesity market, saying it would pay China's Eccogene up to about $2 billion for an exclusive licence to develop an experimental oral drug in the field. Key Points
ReutersUS employers hire virtual providers as weight-loss drug gatekeepers
U.S. employers facing surging costs from paying for Novo Nordisk’s (NOVOb.CO) Wegovy and similar obesity drugs are hiring virtual healthcare providers like Teladoc (TDOC.N) to implement weight-loss management programs, a dozen consultants, pharmacy benefit managers, analysts, and providers told Reuters. Key Points
ReutersRoche enters obesity drugs race with $2.7 bln Carmot deal
The race to grab a slice of the lucrative market for obesity treatments is heating up among drugmakers, with Swiss company Roche (ROG.S) becoming one of the latest entrants following its $2.7 billion deal to buy Carmot Therapeutics (CRMO.O). Key Points
Reuters/cloudfront-us-east-2.images.arcpublishing.com/reuters/LMZH3JPL4RLNHBGR7QRYIMJU4Y.jpg)
Adherence to weight-loss drugs is far higher with Wegovy than older medicines
Forty percent of patients who filled a prescription for Novo Nordisk's (NOVOb.CO) Wegovy to treat obesity in 2021 or 2022 were still taking it a year later, more than three times the rate of adherence with older medicines, according to an analysis of medical records and insurance claims data. Key Points
ReutersTirzepatide approved for weight loss, stronger than semaglutide
Mounjaro is a stronger drug than Ozempic. Now, there's a version of the drug available for patients who aren't diabetic. Key Points
InsiderPfizer drops twice-daily version of obesity pill over side effects
Pfizer (PFE.N) said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting, and its shares fell 5%. Key Points
ReutersBritain to study weight loss drug's potential to get people back to work
Britain is set to explore the potential of Eli Lilly's weight loss drug to improve public health and economic productivity by reducing long-term sickness. Health minister Wes Streeting believes this initiative, supported by substantial investment and research, could significantly impact obesity management and alleviate NHS demands. Key Points
India TodayBody Mass Index could be explained by genes, study finds
Result underscores gender-specific influences on the heritability of BMI. One’s Body Mass Index (BMI) could be explained genetically, researchers have said... Key Points
The Tribune India
US panel recommends children with obesity start counseling from age 6
Children with obesity should receive intensive counseling to promote healthy diet and exercise habits starting at age 6, according to a draft recommendation issued by a panel of U.S. experts on Wednesday. Key Points
ReutersExperimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials
In a mid-stage trial, the highest dose of Eli Lilly's experimental pill orforglipron led to 14.7% weight loss after 36 weeks for people who were obese or overweight, setting a marker in the race to develop effective oral obesity drugs, researchers said on Friday. Key Points
Reutersobesity messes with way your brain reacts to food permanently: study
Obesity may cause changes in the way the brain reacts to sugars and fats, according to a study by Yale University. Those changes may be irreversible. Key Points
InsiderWeight loss from Eli Lilly’s Zepbound reversed slowly after treatment stopped
People who stopped taking Eli Lilly & Co.’s Zepbound after about eight months regained half the weight they’d lost a year later, as per a study. | Health Key Points
Hindustan TimesWeight loss drugs transforming healthcare, may help with addiction
A new class of weight loss drugs is transforming the U.S. healthcare system in ways that could extend to equally hard-to-treat areas like substance abuse, according to speakers at the Reuters Events Total Health conference in Chicago this week. Key Points
Reuters
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S bought Cardior Pharmaceuticals for $1 billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history. Key Points
Economic TimesTema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund
Tema ETFs has launched a new exchange traded fund (ETF) that tracks popular drugmakers like Novo Nordisk (NOVOb.CO) and Eli Lilly (LLY.N), aiming to tap into growing demand for their weight-loss and diabetes drugs. Key Points
Reutersobesity a risk factor for stillbirth, especially at term: Study
Findings suggest that earlier delivery date may help reduce risk of stillbirth for pregnant people with obesity. obesity is a risk factor for stillbirth,... Key Points
The Tribune IndiaNovo, Lilly rivals explore booming weight-loss drug market entry
Novo Nordisk (NOVOb.CO) and Eli Lilly (LLY.N) have pulled ahead in the race for a slice of the weight-loss drugs market, expected to be worth $100 billion by the end of the decade, and rivals are looking to catch up through acquisitions and trials. Key Points
ReutersObese people with dysmorphia hide body behind WhatsApp profile pictures: Study
Many people who are living with obesity, suffer from dysmorphic disorder -- a condition in which a person has a distorted image of their body -- and... Key Points
The Tribune India
Early-morning physical activity has impact on weight management, finds study
According to a study, the best time of day to increase the relationship between daily moderate to vigorous physical activity and obesity appears to be between the hours of 7 a.m. and 9 a.m., despite conflicting epidemiological findings regarding the best timing of physical exercise for weight manage Key Points
The Tribune IndiaBlockbuster weight loss and anti-diabetes drugs could soon be available in India
Aditi Tandon New Delhi, August 8 The USFDA-approved blockbuster weight loss and anti-diabetes drugs—Ozempic and Wegovy—could soon make it to the Indian market. The Ministry of Health on Thursday approved local clinical trial waivers for high-end select drugs approved by... Key Points
The Tribuneobesity may raise risk of blood cancer by over 70 per cent: Study
Smoking habits and exercise may also impact one's likelihood of developing multiple myeloma, said the team from Massachusetts General Hospital. Researchers find... Key Points
The Tribune IndiaExclusive: Manufacturer Lonza says it will not fill obesity drug syringes
Lonza's (LONN.S) chairman has ruled out plans to use its capacity to fill syringes and provide final production steps for new obesity drugs even as rivals scramble for a share of the booming weight-loss market. Key Points
ReutersLilly to build $2.5 bln diabetes drug plant in Germany
Eli Lilly (LLY.N) will build its first plant in Germany for 2.3 billion euros ($2.5 billion) in the western town of Alzey, the U.S. pharmaceuticals maker said on Friday, as the sector scrambles to meet demand for new diabetes and obesity therapies. Key Points
Reuters/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZPFZD22WZZKEZKMWXPV4O4OKAE.jpg)
Novo Nordisk to present new data from weight-loss, diabetes trials
Danish drugmaker Novo Nordisk (NOVOb.CO) said on Tuesday it will present new cardiometabolic disease data, including results from its SELECT trial, at the annual American Heart Association Scientific Sessions from Nov. 11-13. Key Points
ReutersStructure Therapeutics surges on promising early stage obesity drug data
Shares of Structure Therapeutics (GPCR.O) soared 60% on Friday after the drug developer's oral obesity treatment succeeded in a small early-stage study. Key Points
ReutersLilly experimental 'triple G' obesity drug leads to 24.2% weight loss in trial
Eli Lilly on Monday said a mid-stage trial of its next-generation obesity drug candidate "triple G" showed that it led to weight loss of up to 24.2% after 48 weeks, surpassing results seen with other weight loss drugs. Key Points
Reuters